Europe — EMA

Ondansetron Ratiopharm

Ondondansetron, the active ingredient in Ondansetron Ratiopharm, is a 5‑HT3 receptor antagonist presented as a unknown/unknown for unknown use.

Ondansetron

Request sourcing

Pack/s

What is Ondansetron?

Ondondansetron, the active ingredient in Ondansetron Ratiopharm, is a 5‑HT3 receptor antagonist presented as a unknown/unknown for unknown use. It treats and prevents nausea and vomiting associated with chemotherapy, radiation therapy, and postoperative recovery in adults and children.

GNH USA supplies Ondansetron Ratiopharm as a licensed ...

What is Ondansetron used for?

Ondansetron Ratiopharm is ...

What are the side effects of Ondansetron?

Common

What precautions apply to Ondansetron?

Placeholder

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →